blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2161024

EP2161024 - Combination product for the treatment of cancer [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.03.2011
Database last updated on 14.09.2024
Most recent event   Tooltip04.03.2011Application deemed to be withdrawnpublished on 06.04.2011  [2011/14]
Applicant(s)For all designated states
Universitätsklinikum Hamburg-Eppendorf
Martinistraße 52
20246 Hamburg / DE
[N/P]
Former [2010/10]For all designated states
Universitätsklinikum Hamburg-Eppendorf
Martinistrasse 52
20246 Hamburg / DE
Inventor(s)01 / Schumacher, Udo
Am Haidberg 6
21465 Wentorf / DE
02 / Eschenhagen, Thomas
Müggenkampstrasse 31
20257 Hamburg / DE
 [2010/10]
Representative(s)Uexküll & Stolberg, et al
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
[N/P]
Former [2010/10]UEXKÜLL & STOLBERG, et al
Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Application number, filing date08163829.805.09.2008
[2010/10]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP2161024
Date:10.03.2010
Language:DE
[2010/10]
Search report(s)(Supplementary) European search report - dispatched on:EP27.02.2009
ClassificationIPC:A61K31/445, A61K31/40, A61K31/366, A61P35/00
[2010/10]
CPC:
A61K31/366 (EP); A61K31/40 (EP); A61K31/445 (EP);
A61K45/06 (EP); A61P35/00 (EP)
C-Set:
A61K31/366, A61K2300/00 (EP);
A61K31/40, A61K2300/00 (EP);
A61K31/445, A61K2300/00 (EP)
Designated contracting states[2010/46]
Former [2010/10]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Kombinationspräparat zur Behandlung von Krebs[2010/10]
English:Combination product for the treatment of cancer[2010/10]
French:Combinaison pour le traitement de cancer[2010/10]
Examination procedure11.09.2010Application deemed to be withdrawn, date of legal effect  [2011/14]
19.10.2010Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2011/14]
Fees paidPenalty fee
Additional fee for renewal fee
30.09.201003   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2005281868  (LANE EDWARD M [US]) [X] 1-7,12-15 * paragraph [0059]; example 2 *;
 [AD]US2006009506  (WESTWICK JOHN K [US], et al) [AD] 1-15 * table 2 *;
 [A]  - ISHIKAWA MASAAKI ET AL, "Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole", BIOLOGICAL AND PHARMACEUTICAL BULLETIN, (200001), vol. 23, no. 1, ISSN 0918-6158, pages 112 - 115, XP002514903 [A] 1-15 * abstract *
by applicantUS5273995
 US5502199
 US4346227
 US4231938
 US4739073
 US5260440
 US4444784
 EP1491193
 EP1714648
 WO2006017185
    - KAMAT; NELKIN, UROLOGY, (2005), vol. 66, no. 6, pages 1209 - 12
    - RAO ET AL., ONCOGENE, (1998), vol. 17, no. 18, pages 2393 - 402
    - MÜHLHÄUSER ET AL., FASEB JOURNAL, (2006), vol. 20, no. 6, pages 785 - 787
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.